Success Stories: NAILG Guided PhD Candidate in Molecular Biology to NIW Approval for Pioneering Research on Cellular Aging
Client’s Testimonial:
“The support I received throughout my application process was outstanding. Every question I had was addressed promptly and in detail. The team was highly professional and made what could have been a stressful experience feel much more manageable. Special thanks to my attorney for her excellent work on my documents.”
On April 15th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a PhD Candidate in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: PhD Candidate
Country of Origin: China
State of Residence at the Time of Filing: Arizona
Approval Notice Date: April 15th, 2025
Processing Time: 1 month, 21 days (Premium Processing Requested)
Case Summary:
When a PhD candidate contacted the North America Immigration Law Group (NAILG) to pursue a National Interest Waiver (NIW), her research stood out for its clear relevance to one of the most pressing public health challenges in the United States: aging and age-related diseases. As an expert in molecular biology, our client proposed to continue her work on understanding how cellular mechanisms regulate the transition from quiescence to senescence, key to advancing therapeutic strategies for conditions such as Alzheimer’s and dementia. Recognizing the national significance of her endeavor, NAILG immediately began building a strong case that emphasized both the scientific merit and broader societal value of her research.
Throughout the petition process, NAILG carefully documented the breadth and influence of her academic record, including:
● 7 peer-reviewed journal articles, with 1 first-authored
● 1 preprint contributing to current scientific discourse
● A total of 83 citations, evidence of the relevance of her work across the research community
● 1 completed journal review, indicating early contributions to peer-reviewed scholarship.
A compelling recommendation included in her petition underscored the public interest in her continued work:“Considering the value presented by [client]’s research in developing safe therapeutic strategies for cancer treatment and advancing understanding of cellular aging mechanisms, halting [client]’s research would be damaging to public health, healthcare innovation, and efforts to combat age-related diseases. It is therefore within the interests of the U.S. to allow [client]’s research to continue.”
With this clear message and a strategic presentation of her qualifications, NAILG successfully demonstrated that our client’s work meets the criteria for NIW approval, including substantial merit, national importance, and the benefit of waiving the labor certification requirement. Her petition was approved, allowing her to continue her vital research in the United States, where it contributes to scientific advancement and directly aligns with national health priorities.